Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-06-01LIXT3Lixte Biotechnology Director Stuart D. Porter Reports No Securities Ownership
This Form 3 filing reports that Stuart D. Porter, a director of Lixte Biotechnology Holdings, Inc., has no securities ownership in the company as of May 29, 2026. The filing was signed on June 1, 2026, and indicates that Mr. Porter holds the position of director but does not own any shares of Lixte Biotechnology (ticke...
Micro CapBiotechnology